AXQ Capital LP Purchases Shares of 13,698 Pediatrix Medical Group, Inc. (NYSE:MD)

AXQ Capital LP purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 13,698 shares of the company’s stock, valued at approximately $180,000.

Other large investors have also modified their holdings of the company. Quest Partners LLC lifted its position in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the period. Everence Capital Management Inc. increased its position in Pediatrix Medical Group by 7.5% during the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after purchasing an additional 960 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP boosted its holdings in shares of Pediatrix Medical Group by 54.1% in the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC grew its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on MD shares. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Finally, Macquarie assumed coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective for the company. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Stock Up 2.1 %

NYSE:MD opened at $14.51 on Tuesday. The business’s fifty day moving average price is $14.33 and its 200 day moving average price is $13.58. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of -12.09, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. On average, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.